CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• An Overview Of 2026 Life Sciences Industry Trends

  Explore the paradigm shift reshaping life sciences. Learn how connecting data streams across the product lifecycle drives predictive compliance and operational excellence.

• ADC Manufacturing: Practices, Challenges, And The Road Ahead

  ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

• Simpler, Faster, Cheaper Advanced Therapy Manufacturing

  Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

• Empowering Antibody Discovery With ProSpeed™

  Integrating linear expression technology into single B cell workflows accelerates antibody discovery, enabling early functional screening, improved sensitivity, and cost-effective identification of diverse therapeutic candidates.

• Partner Case Study: Accelerating Gene Editing Manufacturing

  Beam Therapeutics partnered with ElevateBio to manufacture BEAM-101, a novel base editing therapy for sickle cell disease, advancing rapid, high-quality production towards clinical trials.

• How Blast Freezing Affects The Quality Of Bottled Drug Substance: Test Results And Insights

  Uneven ice formation during bottle freezing creates a "Volcano Effect," pushing solutes into highly concentrated zones. This test-based study explains this risk to drug substance quality.

• Rethinking Peptones As First-Line Optimization Tools

  Peptones enhance CHO cell growth, viability, and yield, offering a fast, low-risk way to improve bioprocess performance without major process changes.

• Efficient Clone Screening With Increased Process Control And Integrated Cell Health And Titer Measurements With The Cydem VT Automated Clone Screening System

  Automated screening of antibody-producing clones provides real-time cell health and titer data, helping developers identify top-performing candidates earlier and with confidence.

• What the FDA Looks For In Global Development Programs Today

  Mastering the complexities of multi-regional clinical trials requires aligning global data with evolving regulatory expectations to ensure treatment consistency and successful drug approval.

• Fast And Sensitive Mycoplasma Detection Workflow

  Digital PCR enables fast, sensitive mycoplasma detection in cell-based products. Explore how this pharmacopeia-compliant workflow improves accuracy, reduces delays, and supports reliable decision-making.